Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40: Talking Point on the role of presenilin mutations in Alzheimer disease

Open access
Wolfe, Michael S·2007·EMBO reports

Abstract

More than 100 missense mutations in presenilin 1 and 2 are associated with early‐onset dominant Alzheimer disease. These proteins span the membrane several times and are ostensibly the catalytic component of the γ‐secretase complex, which is responsible for producing the amyloid β‐peptide (Aβ) that deposits in the Alzheimer brain. A common outcome of Alzheimer‐associated presenilin mutations is an increase in the ratio of the more aggregation‐prone 42‐residue form of Aβ to the 40‐residue variant, which is often referred to as a presenilin ‘gain of function’. An apparent paradox is that most of these mutant presenilins have reduced proteolytic efficiency, which forms part of the counter argument that presenilin ‘loss of function’ can cause the neuronal dysfunction and death that lead to the disease. In this review, a unifying hypothesis is presented that puts forward a biochemical mechanism by which slower less‐efficient forms of the protease can result in a greater proportion of 42‐residue Aβ.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.embor.7400896

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 192

Metadata

Authors
Wolfe, M. S.
Venue
EMBO reports
Published
2007-02
Volume
8
Issue
2
Pages
136-140
ISSN
  • 1469-221X (ISSN-L)
  • 1469-3178
OpenAlex
W1837316886
Cited by
192
References
13
FWCI
13.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40: Talking Point on the role of presenilin mutations in Alzheimer disease. https://app.cochat.ai/papers/10.1038/sj.embor.7400896
The paper
Wolfe, M. S. (2007). When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40: Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO reports. https://doi.org/10.1038/sj.embor.7400896

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.